Aquatic Capital Management’s Gilead Sciences GILD Stock Holding History

Aquatic Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.59M	Buy	+47,273	New	+$6.62M	0.19%	140
2025 Q2	–	Sell	-38,303	Closed	-$4.29M	–	1349
2025 Q1	$4.29M	Buy	+38,303	New	+$3.95M	0.11%	243
2024 Q2	–	Sell	-227,900	Closed	-$16.7M	–	1366
2024 Q1	$16.7M	Buy	+227,900	New	+$17.5M	0.55%	46
2023 Q4	–	Sell	-46,100	Closed	-$3.46M	–	1441
2023 Q3	$3.46M	Buy	+46,100	New	+$3.55M	0.14%	165
2022 Q1	–	Sell	-2,900	Closed	-$211K	–	1245
2021 Q4	$211K	Buy	+2,900	New	+$200K	0.41%	32

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Aquatic Capital Management's GILD Position: Q1 2026 in Review

Aquatic Capital Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 47,273 shares worth $6.59M. The stake represents 0.19% of the portfolio and ranks #140 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in GILD as recently as Q1 2025.

Aquatic Capital Management first reported a position in GILD in Q4 2021 and has held it in 5 quarters since. The position peaked at $16.7M in Q1 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Aquatic Capital Management held 47,273 shares of Gilead Sciences worth $6.59M as of Q1 2026.
Gilead Sciences was a new Aquatic Capital Management position in Q1 2026.
Gilead Sciences made up 0.19% of Aquatic Capital Management's portfolio in Q1 2026, its #140 holding.
Aquatic Capital Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 5 quarters since.
Aquatic Capital Management's Gilead Sciences position peaked at $16.7M in Q1 2024.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.